Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Telerehabilitation vs In-Clinic Rehab for Poststroke Arm Function
Key clinical point: Telerehabilitation is noninferior to in-clinic rehabilitation for poststroke arm dysfunction.
Major finding: Arm Fugl-Meyer score improved by approximately 8 points in both the in-clinic and telerehabilitation groups.
Study details: A randomized, assessor-blinded, noninferiority trial including 124 patients with stroke and arm deficits.
Disclosures: The study was funded by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development and several grants from the National Institute of Neurological Disorders and Stroke. Dr. Cramer has an ownership interest in TRCare, a company that plans to market a telerehabilitation system and was not involved in the study. In addition, he is a consultant or advisor for MicroTransponder, Dart Neuroscience, Neurolutions, Regenera, Abbvie, SanBio, and TRCare.
Cramer SC et al. ISC 2019, Abstract LB23.